Zhejiang Hisun Pharmaceutical Balance Sheet Health
Financial Health criteria checks 4/6
Zhejiang Hisun Pharmaceutical has a total shareholder equity of CN¥8.3B and total debt of CN¥5.3B, which brings its debt-to-equity ratio to 64.5%. Its total assets and total liabilities are CN¥17.4B and CN¥9.1B respectively. Zhejiang Hisun Pharmaceutical's EBIT is CN¥393.3M making its interest coverage ratio -2.2. It has cash and short-term investments of CN¥1.6B.
Key information
64.5%
Debt to equity ratio
CN¥5.35b
Debt
| Interest coverage ratio | -2.2x |
| Cash | CN¥1.57b |
| Equity | CN¥8.29b |
| Total liabilities | CN¥9.14b |
| Total assets | CN¥17.43b |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: 600267's short term assets (CN¥6.4B) do not cover its short term liabilities (CN¥7.2B).
Long Term Liabilities: 600267's short term assets (CN¥6.4B) exceed its long term liabilities (CN¥1.9B).
Debt to Equity History and Analysis
Debt Level: 600267's net debt to equity ratio (45.6%) is considered high.
Reducing Debt: 600267's debt to equity ratio has reduced from 148.5% to 64.5% over the past 5 years.
Debt Coverage: 600267's debt is well covered by operating cash flow (28.3%).
Interest Coverage: 600267 earns more interest than it pays, so coverage of interest payments is not a concern.